NATALIE DIAZ-CABRERA, M.D.
Allergy & Immunology Physician in MIAMI, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What stands out: NATALIE DIAZ-CABRERA, M.D. filed 653 Medicare Part D claims in 2023 across MIAMI, Florida. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.
NATALIE DIAZ-CABRERA, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
NATALIE DIAZ-CABRERA, M.D. at a glance
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Florida
How Allergy & Immunology Physician compares to other specialties among Florida providers
Allergy & Immunology Physician share within Florida
Allergy & Immunology Physician is one of the more visible NUCC categories in Florida
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Allergy & Immunology Physician (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Allergy & Immunology Physician ABMS/AOA estimate
Est. board-certified rate (Allergy & Immunology Physician) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Allergy & Immunology Physician US NPIs
Specialty board-certified rate — Allergy & Immunology Physician estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
NATALIE DIAZ-CABRERA, M.D. is a Allergy & Immunology Physician provider practicing in MIAMI, Florida, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1871026203. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.
NATALIE DIAZ-CABRERA, M.D. appears in the CMS NPPES registry as a Allergy & Immunology Physician provider holding M.D. credentials at 2000 SW 27TH AVE STE 301, MIAMI, FL, 33145, with a listed phone of (305) 461-2010. NPI 1871026203 was issued on 04/04/2017. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what DIAZ-CABRERA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 653 prescription claims written by this provider, covering 131 Medicare beneficiaries and totaling roughly $184K in drug spend, split 36% brand-name and 64% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Allergy & Immunology Physician is a narrow specialty nationwide, with 3,390 enrolled providers across 52 states and an average of 764 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1871026203 |
|---|---|
| Specialty | Allergy & Immunology Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 04/04/2017 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm NATALIE DIAZ-CABRERA, M.D.'s current license status, disciplinary history, and board certifications with the Florida Board of Medicine in Florida before relying on this page for a clinical or care decision.
How we sourced this profile
Hospital and facility affiliations
Facilities where NATALIE DIAZ-CABRERA, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for NATALIE DIAZ-CABRERA, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$840
Largest payer
Regeneron Healthcare Solutions, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — Florida FLDOH 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to NATALIE DIAZ-CABRERA, M.D.. To verify NATALIE DIAZ-CABRERA, M.D.'s current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
36% brand-name claims vs 64% generic, on 653 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 852
- Total Day Supply
- 22,744
- Brand vs Generic
- 36% brand / 64% generic
- Brand Drug Cost
- $170K
- Generic Drug Cost
- $13K
- Antibiotic Claims
- 33
Patient Demographics
- Average Patient Age
- 72.6 years
- Avg HCC Risk Score
- 1.70
- Gender Split
- 69% female / 31% male
- Age Distribution
- <65: 12, 65-74: 64, 75-84: 40, 85+: 15
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
| Drug | Claims |
|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 53 |
| Levocetirizine Dihydrochloride | 51 |
| Ipratropium Bromide | 42 |
| Ammonium Lactate | 37 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 37 |
| Azelastine Hcl | 29 |
| Prednisone | 28 |
| Triamcinolone Acetonide | 27 |
| Fluticasone Propionate | 22 |
| Dupixent Pen Dupilumab | 21 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Allergy & Immunology Physician Overview
How NATALIE DIAZ-CABRERA, M.D. fits within the Allergy & Immunology Physician landscape nationally.
NATALIE DIAZ-CABRERA, M.D.'s 653 claims are below the specialty average of 764.
Nearby Allergy & Immunology Physician Providers in Florida
Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as DIAZ-CABRERA.
Compare Allergy & Immunology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Florida
Frequently Asked Questions
What is NATALIE DIAZ-CABRERA, M.D.'s specialty? ▼
How much does NATALIE DIAZ-CABRERA, M.D. prescribe under Medicare Part D? ▼
Where is NATALIE DIAZ-CABRERA, M.D. located? ▼
What is NATALIE DIAZ-CABRERA, M.D.'s NPI number? ▼
Does NATALIE DIAZ-CABRERA, M.D. prescribe more brand-name or generic drugs? ▼
How many Allergy & Immunology Physician providers are there in the US? ▼
What drugs does NATALIE DIAZ-CABRERA, M.D. prescribe most often? ▼
Does NATALIE DIAZ-CABRERA, M.D. accept Medicare? ▼
How can I verify NATALIE DIAZ-CABRERA, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology